Documenti di Didattica
Documenti di Professioni
Documenti di Cultura
COM/SE2016
Compatibility of
Commonly Used IV Drugs
A
ll
Co
py
rig ed.
Detroit, Michigan
re
ht
se
rv
©
20
16
Re
M
pr
cM
od
uc
ah in w
T
he number of available IV
tio
on
medications continues to
n
Pu
bl
hi
G
ro
in
le
ss
ot
to be administered concurrently.
he
tp
rw
er
is
m
e
is
P H A R M AC Y P R AC T I C E N E WS .CO M /S E 2 0 1 6 P H A R M AC Y P R AC T I C E N E WS S P E C I A L E D I T I O N • 2 0 1 6 61
Table. Compatibility of Selected IV Drugs (Acyclovir through Dextrose 5% in water)
Ampicillin-sulbactam
Dextrose 5% in water
Calcium gluconate
Dexmedetomidine
Calcium chloride
Dexamethasone
Anidulafungin
Cisatracurium
Azithromycin
Ciprofloxacin
Amiodaronea
Caspofungin
Clindamycin
Bumetanide
Daptomycin
Ceftriaxone
Argatroban
Atracurium
Ceftaroline
Aztreonam
Ampicillinb
Bivalirudin
Cefepime
Cefazolin
Acyclovir
Amikacin
Cefoxitin
A
ll
Acyclovir C I C C I C C C C I C C C C N C I C C C I N C I C C C Acyclovir
rig
Co
Amikacin C C I N N C C C N C C C C C C C C C C C N C C C C C C Amikacin
Amiodaronea I C C I I C N C I N I N C N C N C N C N C C C C I C C Amiodaronea
ht
py
rig ed.
Ampicillinb Ampicillinb
ht
se
C N I I N C C N C N C N N N I N N N N N N N N C N C I
Ampicillin-sulbactam I N I I N C C N C N C N N N I N C N N N I N N C N C A Ampicillin-sulbactam
rv
Anidulafungin C C C C C C C C C C C C C C C C C C N C C C C N C C C Anidulafungin
20
Argatroban C C N C C C C C C C C C C C C C I C N C C C C C C C C Argatroban
16
Re
Atracurium C C C C N N C C C C C C C C C C N C N C C N C C C C C Atracurium
M
pr
Azithromycin C N I C C C C C C N C C C C N C C C C N N C N C C C C Azithromycin
cM
od
Aztreonam I C N C N N C C C N C C C C C C C C N C C C C C C C C Aztreonam
Bivalirudin C C I I C C C C C C C C C C I C C C N C C C C C C C C Bivalirudin
uc
ah in w
Bumetanide C C N C N N C C C C C C C C C C C C C C N C C C C C C Bumetanide
tio
on
Pu
Cefazolin C C N C N N C C C C C C C I C I N C N C N N C C C C C Cefazolin
ho
hi
Cefepime I C C C N C C I N C C C C N C I N N N N I N C C C C C Cefepime
ng
le
Cefoxitin C C N C N N C C C C C C C C C I C N N C N N C C C C C Cefoxitin
or
Ceftaroline C C C N N N N N N C N N C C C I N N N N C C C N C N C Ceftaroline
G
ro
Ceftriaxone C C N C N N C C C N C C C I I I C N C N N C I C C C C Ceftriaxone
in
up
Ciprofloxacin I N C I N I C C C N C C N N A C N I N C N C I C I C C Ciprofloxacin
pa
Cisatracurium N C C C N N C C N C C C C N C C N N N C C C C C C C C Cisatracurium
un ou
rt
Clindamycin C C C C N N C C C N C C C C C I C C C C I I C C C C C Clindamycin
w
le
Daptomycin I C C I C C N C C C C C C C C C C C C N C C C C C C I Daptomycin
ith
ss
Dexamethasone C C I C N N C C C C C C C N N I C C C C C I C C C C C Dexamethasone
ot
Dexmedetomidine C C C I C C C C C C C C C C C C C C C N C C C C C C C Dexmedetomidine
he
tp
Diltiazem N C C I N N C C C C C C C C C C C I C C C C C C C C C C Diltiazem
er
Diphenhydramine N C C C I N C C C C N C C C C C I I I C I C C C C I C C Diphenhydramine
is
m
e
is
Dobutamine I C N I I I C C C C C N N C N C I N I N I C C C C I C C Dobutamine
no
si
Dopamine I C C I N N C C C C C C C C C C I N C C C C C C C C C C Dopamine
on
te
Doripenem C C C N N N C N N C N N C N C C N N N C N C N N C C N C Doripenem
d.
is
Doxycycline C C C I I I C C C C C C C C C C I N I N C N C C C I C C Doxycycline
pr
Enalaprilat C C C C N N C C C C C C C C C I C I C C C N C C C C C C Enalaprilat
oh
Epinephrine I C C C N N C C C C C C C C C C C N C N C N C C C C C C Epinephrine
Eptifibatide I C N C C C C C C C C C C C C N C C C N C C C C C C N N Eptifibatide
ib
Ertapenem C C I C N N I C C C C C C C C I N N N N N C C N C C C I Ertapenem
ite
Esmolol I C C I N N C C C C C C C C C C C N C N C N C C C I C C Esmolol
d.
Famotidine C C C C N N C C C N C N C C C C N I N C N N C C C C C C Famotidine
KEY
A = Physically compatible for at least 2 hours H = Physically compatible for at least 1 hour
C = Physically compatible I = Incompatible
D = Physically compatible in dextrose 5% in water N = Information on compatibility is not available or not adequate
E = Physically compatible for at least 5 minutes R = Physically compatible for 24 hours under refrigeration
G = Physically compatible in glass bottle only S = Physically compatible in 0.9% sodium chloride
62 P H A R M AC Y P R AC T I C E N E WS .CO M /S E 2 0 1 6
Table. Compatibility of Selected IV Drugs (Acyclovir through Dextrose 5% in water)
Ampicillin-sulbactam
Dextrose 5% in water
Calcium gluconate
Dexmedetomidine
Calcium chloride
Dexamethasone
Anidulafungin
Cisatracurium
Azithromycin
Ciprofloxacin
Amiodaronea
Caspofungin
Clindamycin
Bumetanide
Daptomycin
Ceftriaxone
Argatroban
Atracurium
Ceftaroline
Aztreonam
Ampicillinb
Bivalirudin
Cefepime
Cefazolin
Acyclovir
Amikacin
Cefoxitin
A
ll
Fentanyl C C N C N N C C C N C C C C C C C N C C C N C C C C C C Fentanyl
rig
Co
Fluconazole C C C I I N C C C C C C C C N C C C C C N C C N C C C C Fluconazole
Furosemide C C N C N N C C I N C C C C C I C C C C C I N C C C C C Furosemide
ht
py
Gentamicin N C C I N N C C C N C C C C C C N N C C N C C C C N C C Gentamicin
s
rig ed.
re
Heparin C I I C N N C C N C C C C C C I C C C C C I N C C C C C Heparin
ht
se
Hydromorphone C C C C N C C C C C C C C C C C N C C C C C C C C C C C Hydromorphone
rv
Imipenem-cilastatin C C I I N N C C C N N C C N N C C C C N I N C C I C C N Imipenem-cilastatin
Insulin, regularc C N N C N N C C N N C C C C C C C H I C C N N C C C C C Insulin, regularc
20
Labetalol I C C I N N C C C C C N C C C C N N I I I N N N C I C C Labetalol
16
Re
Levofloxacin I C I I C C C C C N C C C N C C I C I C C N C C C C C C Levofloxacin
cM
od
Linezolid C C C C C C C C C C C C C C C C C C C N N C C C C C C C Linezolid
uc
ah in w
on
Lorazepam C C C C I I C C C C I N C C C N C C C C C C C C C C C N Lorazepam
n
Pu
Meropenem N N I I N N C C N C N C N N N C N N N N N I N N C C C I Meropenem
ho
hi
Methylprednisolone C C N C N I C C C C C C C I I I C C I C C I N C C C C N Methylprednisolone
ng
le
Metoclopramide N C C C N N C C C C C C C C C C C I C C C C C C C C C C Metoclopramide
or
Metronidazole C C C I C C C C C C I C C C C N C C C C C C C C I C C N Metronidazole
G
ro
Micafungin N N I N N N N N N N N N C C C N N N N N N N I N N N N C Micafungin
in
up
Midazolam I C C I I I C C C I C C N C C C C I C C C C C N C I C C Midazolam
pa
Mycophenolate I C C I I I C C C I I C C C I C I N I N I C C I C I C C Mycophenolate
w
le
Nicardipine I C C I I I C C C I C C C C C C C N C N C C C N C I C C Nicardipine
ith
ss
Nitroglycerin C C C C N N C C C C C C C C C C C N C N C N C C I C C G Nitroglycerin
ot
Nitroprussided I C N C N N C C N C C C C C C I C N C N C N N C C C C C Nitroprussided
he
tp
Norepinephrine N C N I N N C C C N C C C C C C C N C C C C C C C C C C Norepinephrine
rw
Octreotide C C C C C C C C C C C C C C C C C C C N C C C C C C C C Octreotide
er
Ondansetron I C C I I I C C C C C C C C C C C I C C N C C C C C C C Ondansetron
is
m
Pantoprazolee C Pantoprazolee
is
N N N C C C C C I C I N C I N N N I N C C I I N I I I
no
si
Penicillin G C C C N C N N N C N C N C C C N C N C N C N N C N C N C Penicillin G
on
te
Phenylephrine I C C I N N C C C C C C C C C C C N C N C N C C C C C C Phenylephrine
d.
is
Phenytoin I I I I I I I I I I I I I I I I I I I N I I N I I I I I Phenytoin
pr
Phytonadione N C N N N N N N C N C N C C C N C N C N C N N C N C N C Phytonadione
oh
Piperacillin-tazobactam I C I C N N C C N N C C C C C I N C N N N I N C C C C C Piperacillin-tazobactam
Potassium chloride C C N N N N C C C N C C C C C C C C C C C C C C C C C C Potassium chloride
ib
Propofol C I N N H N N N N N C N C I C N C N C C C I N C N C C C Propofol
d.
Magnesium sulfate
Diphenhydramine
Lactated Ringer’s
Liposomal amphoB
Hydromorphone
Metoclopramide
Insulin, regularc
Levofloxacin
Dobutamine
Fluconazole
Epinephrine
Doxycycline
Meropenem
Eptifibatide
Furosemide
Gentamicin
Famotidine
Doripenem
Lorazepam
Ertapenem
Enalaprilat
Dopamine
Diltiazem
Labetalol
Linezolid
Fentanyl
Mannitol
Esmolol
Heparin
A
Acyclovir N N I I C C C I I C I C C C C N C C C C I C I C C C C C N C N Acyclovir
ll
Amikacin C C C C C C C C C C C C C C C C I C C N C C C C I C C C N C C Amikacin
rig
Co
Amiodaronea C C N C C C C C N I C C N C N C I C I N C N I C N C N C I N C Amiodaronea
ht
py
Ampicillinb N I I N N I N N C N N N N I N N N N N N N N C C I I N C N N N Ampicillinb
ht
se
Ampicillin-sulbactam N N I N N I N N C N N N N N N N N C N N N R C C I I N N N I N Ampicillin-sulbactam
rv
Anidulafungin C C C C C C C C C I C C C C C C C C C C C N C C C C I C C C C Anidulafungin
20
Argatroban C C C C N C C C C C C C C C C C C C C C C C C C C C C C C C C Argatroban
16
Re
Atracurium C C C C N C C C C C C C C C I C N C C N C N C C N C C C N C C Atracurium
Azithromycin C C C C C C C C C C C N N C N N C C N N C C N C C C C C C C C Azithromycin
M
pr
Aztreonam C N C C N C C C C C C C C C C C C C N C C C C C I I C C N C C Aztreonam
cM
od
Bivalirudin C C N C N C C C C C C N C C C C C C C C N N C C C N C C C C C Bivalirudin
uc
ah in w
Bumetanide C C N C C C C C C C C C C C C C C C C C C C C C C C C C N C C Bumetanide
tio
on
Caspofungin C C C C C C I C N I C C C C I C I C C C C C C C I N C C C I C Caspofungin
bl
Cefazolin C I I I N I C C C N C N C C C N C N C C N C I C C C N C N C C Cefazolin
is
ho
hi
Cefepime I I N N N N I N C N N I N C C N C C C H N C C C I C I I N C I Cefepime
ng
le
Cefoxitin C I I C N I C C C N C N C C C C C C C I I C I C C C C C N I C Cefoxitin
Ceftaroline C C N C C N C N N N N C C C C C C C N C I C C N N C N C N C C Ceftaroline
or
Ceftriaxone C I I C N C C C C N C N C N C N C C I C I C C N C C N C N C C Ceftriaxone
ro
in
Ciprofloxacin C C C C C N N N C C N N N C I C I C N N N C N C I C I N I I C Ciprofloxacin
up
pa
Cisatracurium C C C C N C C C C C C C C C N C N C C N N I C C N C C C N N C Cisatracurium
un ou
rt
Clindamycin C C C C N C C C C N C C C N C C C C C C N C C C C C C C N C C Clindamycin
w
le
Daptomycin C C C C C C C C C C C C C C C C C C I C C C C C C C C C C C C Daptomycin
ith
ss
Dexamethasone C I I C C I C C C C I C C C C N C C C C I N C C C C I C C C C Dexamethasone
ot
Dexmedetomidine C C C C N C C C N C C C C C C C C C C C C C C C C C C C C C C Dexmedetomidine
he
rw
Diltiazem C C C C C C C C C C C C C I C N C C N C N C C I C C C C N C Diltiazem
er
Diphenhydramine C C C C C C C C C C C C C I C N C C I C C C C C C C C C I C Diphenhydramine
is
m
Dobutamine C C C C C C C C I C C C C N C N C N N C C C C I C N C C C C Dobutamine
e
is
no
si
Dopamine C C C C C C C C C C C C C N C C C C N C C C C I C C C C C C Dopamine
on
Doripenem C C C C N C N N N C C C C C C C C N C C N C C N C C C N C C Doripenem
te
Doxycycline C C C C N C C C C C C C C I C I C C C C C C C I C C C N I C Doxycycline
d.
is
Enalaprilat C C C C C C C C C C C C C C C C C C C C C C C C C C C C C C Enalaprilat
pr
Epinephrine C C C C N C C C C C C C C C C C C C N C C C C C C C C N C C Epinephrine
oh
Eptifibatide C C C C N C C C N C C C C I C C C C N C N C C C C C C C C C Eptifibatide
ib
Ertapenem C C I C N C C C N C C N C C C C C N C C C C C C C C C N C C Ertapenem
ite
Esmolol C C C C C C C C C C C C C I C C C C C C C C C C C C C N N C Esmolol
d.
KEY
A = Physically compatible for at least 2 hours H = Physically compatible for at least 1 hour
C = Physically compatible I = Incompatible
D = Physically compatible in dextrose 5% in water N = Information on compatibility is not available or not adequate
E = Physically compatible for at least 5 minutes R = Physically compatible for 24 hours under refrigeration
G = Physically compatible in glass bottle only S = Physically compatible in 0.9% sodium chloride
64 P H A R M AC Y P R AC T I C E N E WS .CO M /S E 2 0 1 6
Table. Compatibility of Selected IV Drugs (Diltiazem through Metoclopramide)
Magnesium sulfate
Diphenhydramine
Lactated Ringer’s
Liposomal amphoB
Hydromorphone
Metoclopramide
Insulin, regularc
Levofloxacin
Dobutamine
Fluconazole
Epinephrine
Doxycycline
Meropenem
Eptifibatide
Furosemide
Gentamicin
Famotidine
Doripenem
Lorazepam
Ertapenem
Enalaprilat
Dopamine
Diltiazem
Labetalol
Linezolid
Fentanyl
Mannitol
Esmolol
Heparin
A
Famotidine C C C C C C C C C C C C C N C C C C N C C C C C C C C N N C Famotidine
ll
Fentanyl C C C C C C C C C N C C C C C C C C C C C C C C C C C N C C Fentanyl
rig
Co
Fluconazole C C C C C C C C C C C C C N C C C N C C C C C N C C C C C C Fluconazole
ht
py
Furosemide I I N N C I C C I C I N C N N C C C N N C I C C C N C C C N Furosemide
s
rig ed.
Gentamicin C C C C C C C C C C C C C C N I C C N C C C C I C C C C C C Gentamicin
re
Heparin N N N C C I C C C C C C C C C I C C C N N I C C C C C C N C Heparin
ht
se
Hydromorphone C C C C C C C C C C C C C C C C C C C C C C C C C C C C C C Hydromorphone
rv
Imipenem-cilastatin C C N C N C C C C N C C C N C C C C C C N C C I I C I N C C Imipenem-cilastatin
20
Labetalol C C C C C C C C C C C C C C N C N C C I C C C I C C C N C C Labetalol
M
cM
Levofloxacin C C C C C C C C C C C C C C I C I C C N C N C I N N C N C C Levofloxacin
od
Linezolid C C C C C C C C C C C C C C C C C C C C C C C C C C C C N C Linezolid
uc
ah in w
on
(AmBisome) (AmBisome)
n
Lorazepam C C C C C C C C C C C C C C C C C C I C C N N C I C C C C C Lorazepam
Pu
Mannitol C C C C C C C C C C C C C C C C C C I C C N C C I C C I C C Mannitol
is
ho
hi
Meropenem C C C C N N C N C N N N N C C C C C N C N I N C I C C I N C Meropenem
ng
le
Methylprednisolone N I C C C I C C C C N N C C C C N C C C C N C N C C I C N C Methylprednisolone
Metoclopramide C C C C C C C C C C C C C C N C C C C C C C C C I C C C C C Metoclopramide
or
Metronidazole C C C C C C C C C C C C C C C C C C C C C N C C I C C C C C C Metronidazole
ro
in
Micafungin I N I C C N N I C N C N N N C N C C N I I C I N N C C N N N N Micafungin
up
pa
Midazolam C C N C C C C C C I C C C C N C C C N N C N C C I C C C N N C Midazolam
un ou
rt
le
Mycophenolate C C C C N C C C I N C C C C I C I C I C C N C C I C C C I I C Mycophenolate
ith
ss
Nicardipine C C C C N C C C C I C C C C I C N C I N C I C C I N C C I N C Nicardipine
ot
Nitroglycerin C C C C N C C C C C C C C C N C C C C C C G I C C C C C N C C Nitroglycerin
he
Nitroprussided C I N C N C C C C C C C C C C C C C N C C C I C C C C C N C C Nitroprussided
tp
Norepinephrine C C C C C C C C N C C C C C N C C C C N C C N C N C C C C C C Norepinephrine
rw
er
Octreotide C C C C N C C C C C C C C C C C C C C C C N C C C C C C C C C Octreotide
is
m
Ondansetron C C C C C C C C C I C C C C I C C C C N C C C C I I C C N N C Ondansetron
e
is
no
Pantoprazolee I I I N C C N N N C I I I I N N N N C N I C I I C I N N I I N Pantoprazolee
si
on
Penicillin G C C I C N I C C N N C C C C C C C C C C N C N N N N C C N C C Penicillin G
te
Phenylephrine C C C C C C C C C C C C C C N C C C C I C C C C C C C C N C C Phenylephrine
d.
is
Phenytoin I I I I N I I I I I N N I N I I I I I I I I I I I I I I N I I Phenytoin
pr
Phytonadione N C N C N C C C N N C C C C C C C N C C C C N N N N I C N N C Phytonadione
oh
Piperacillin-tazobactam I C I C N I C C C N C I C C C N C C N I I C I C C C C C N C C Piperacillin-tazobactam
ib
Propofol N C N N I C C N N N C C C C C I C C C C C C I N N C N C N I I Propofol
Sodium bicarbonate N I I I C I C I C C C C C C C C C I I C N N C C I C C C I C C Sodium bicarbonate
Sodium chloride 0.9% C C C C C C C C C C C C C C C C C C R C C N C C I N C N R C C Sodium chloride 0.9%
Tacrolimus C C C C C C C C N C C C C C N C C C C C C N C C C C C C C C C Tacrolimus
Tobramycin C C C C C C C C C C C C C C C C I C C N C C C C I C C C N C C Tobramycin
TMP-SMX C I I I N I N I C C N I I I I I I C I I N N C N C C N I N I I TMP-SMX
Vancomycin C C C C C C C C C C C C C C I C I C N C C C C C I C C C C I C Vancomycin
Vasopressin C C C C N C C C N C C C C C N C C C C N C N C C C C C C C C C Vasopressin
Vecuronium C C C C N C C C C C C C C C I C C C I C C C C C I C C C C I C Vecuronium
Voriconazole C C C C C C C C N C C C C C C C C N C C C N C C C C C C C C C Voriconazole
a
Infusions exceeding 2 hours must be administered in glass or polyolefin containers. b Unstable in solutions containing dextrose. c Adsorbs to containers, tubing, and filters with which it comes into contact. d Protect from
light. e Testing was performed with ethylenediaminetetraacetic acid (EDTA)-free formulation.
Table. Compatibility of Selected IV Drugs (Metronidazole through Voriconazole)
Piperacillin-tazobactam
Penicillin G potassium
Sodium bicarbonate
Potassium chloride
Morphine sulfate
Norepinephrine
Mycophenolate
Nitroprussided
Metronidazole
Phenylephrine
Pantoprazolee
Phytonadione
Nitroglycerin
Voriconazole
Ondansetron
Vancomycin
Vecuronium
Vasopressin
Tobramycin
Nicardipine
Micafungin
Octreotide
Midazolam
Tacrolimus
Phenytoin
TMP-SMX
Propofol
Acyclovir C N I N I I C I N C I N C I I N I C I C C C I C C C C I C Acyclovir
A
Amikacin C N C C C C C C C C C N C C I C C C N I C C C C I C C C C Amikacin
ll
Amiodaronea C I C C C C C N N C C N C C I N I N I N I N C C I C C C C Amiodaronea
rig
Co
py
Ampicillinb N N C C Ampicillinb
rig ed.
C N I N I I N N N C I C C N I N N N N H N C N N I
re
Ampicillin-sulbactam C N I N I I N N N C I C N N I N N N N N N C N N I N N C C Ampicillin-sulbactam
ht
se
Anidulafungin C N C C C C C C C C C C N C I N C C I N I C C C C C C C C Anidulafungin
rv
Argatroban C N C C C C C C C C C C N C I N C C C N C C C C C C C C C Argatroban
20
Atracurium C N C C C C C N C C C I C C I C N C N N I C C C N C C N N Atracurium
16
Azithromycin C N I N I I C C N C C C N C I N N N C N C C C N C C C C C Azithromycin
Re
Aztreonam I N C C I C C C C C C I C C I C C C N C C C C C N N C C C Aztreonam
M
pr
Bivalirudin C N C C C C C C C C C N N C I N C C C N C C C C C I C C C Bivalirudin
cM
od
Bumetanide C C N C C C C C C C C C C C I C C C N C C C C C I C C C C Bumetanide
uc
ah in w
on
Caspofungin N N C C C C C I C C C N N C I N I C I N I C C C I C C C C Caspofungin
Pu
Cefazolin C N C C I C C C C C C N C C I C N C N C C C C N I N C C C Cefazolin
bl
Cefepime C N I N N N N N N C I I N N I N C C N N C C I N C N C I I Cefepime
is
ho
hi
Cefoxitin C N C C I C C C C C C N C C I C N C N C I C C C I N C C C Cefoxitin
ng
le
Ceftaroline C N C C N N N N C N C C N N N N N C I C C C N C C N C N C Ceftaroline
Ceftriaxone C N C C I C C C C C N C C C I C N C N C C C C I I N C C C Ceftriaxone
or
Ciprofloxacin C N C N C C N N C C C I N N I N I C I I N C C C N N C C C Ciprofloxacin
ro
in
Cisatracurium C I C C C C C N C C C I N C N N N C N N N C C C N C C N C Cisatracurium
up
pa
Clindamycin C N N C I N C C C C C N C C I C C C N C C C C N I C C C C Clindamycin
un ou
rt
Daptomycin I N C C C C I C C C C I N C I N C C C N C C C C C I C C C Daptomycin
w
le
Dexamethasone C N I C I I C C C C C I C C I C C C N C C C C I I N C C C Dexamethasone
ith
ss
Dexmedetomidine C N C C C C C C C C C I N C I N C C C C C C C C C C C C C Dexmedetomidine
ot
D5W N C C C C C G C C C C C C C I C C C C C C C C C N C N C C D5W
he
Diltiazem C I C C C C C C C C C I C C I N I C C N N C C C C C C C C Diltiazem
tp
Diphenhydramine C N C C C C C I C C C I C C I C C C N C I C C C I C C C C Diphenhydramine
rw
er
Dobutamine C I N C C C C N C C C I I C I N I C I N I C C C I C C C C Dobutamine
is
m
Dopamine C C C C C C C C C C C N C C I C C C N N I C C C I C C C C Dopamine
e
is
no
Doripenem C C C C N N N N C N C C N C N N N C I I C C C C N C N N C Doripenem
si
on
Doxycycline C N C C C C C C C C C C I C I C I C N C I C C C I C C C C Doxycycline
te
Enalaprilat C N C C C C C C C C C N C C I C C C C C C C C C N C C C C Enalaprilat
d.
is
Epinephrine C I C C C C C C C C C N C C I C C C N N I C C C I C C C C Epinephrine
pr
Eptifibatide C C C C I C C C N C C N N C I N C C C N C C N C C C N C N Eptifibatide
oh
Ertapenem C N I C N I C C C C I C N C I N N C C N C C C C C C C C C Ertapenem
ib
Esmolol C C C C C C C C C C C I C C N C C C C C C C C C N C C C C Esmolol
ite
Famotidine C N C C C C C C C C C I C C N C I C C C C C C C I C C C C Famotidine
d.
Fentanyl C N C C C C C C C C C I C C I C C C N C C C C C I C C C C Fentanyl
KEY
A = Physically compatible for at least 2 hours H = Physically compatible for at least 1 hour
C = Physically compatible I = Incompatible
D = Physically compatible in dextrose 5% in water N = Information on compatibility is not available or not adequate
E = Physically compatible for at least 5 minutes R = Physically compatible for 24 hours under refrigeration
G = Physically compatible in glass bottle only S = Physically compatible in 0.9% sodium chloride
66 P H A R M AC Y P R AC T I C E N E WS .CO M /S E 2 0 1 6
Table. Compatibility of Selected IV Drugs (Metronidazole through Voriconazole)
Piperacillin-tazobactam
Penicillin G potassium
Sodium bicarbonate
Potassium chloride
Morphine sulfate
Norepinephrine
Mycophenolate
Nitroprussided
Metronidazole
Phenylephrine
Pantoprazolee
Phytonadione
Nitroglycerin
Voriconazole
Ondansetron
Vancomycin
Vecuronium
Vasopressin
Tobramycin
Nicardipine
Micafungin
Octreotide
Midazolam
Tacrolimus
Phenytoin
TMP-SMX
Propofol
Fluconazole C N C C C C C C C C C I C C N C C C N C C C C C I C C C C Fluconazole
A
Furosemide C C N N I I N C N C I N C N I C C C N C C C N C I I N I C Furosemide
ll
Gentamicin C N C C C C C C C C C N C C I C N C N I C C C C I C C C C Gentamicin
rig
Co
Heparin C C C N I N C C C C C N C C I C C C N C C C C I I I C C C Heparin
ht
py
Hydromorphone C C C C C C C C C C C N C C I N C C C C I C C C C C C C N Hydromorphone
s
rig ed.
Imipenem-cilastatin C N N C I I C N C C C C C C I C N N N C I R C C I N C I C Imipenem-cilastatin
re
Labetalol C I C C C C C C C C C I N C I C I C C C N C C C N C C C C Labetalol
rv
Levofloxacin C I C C C C I I N C C I N C I N I C N I C C C C C C C C C Levofloxacin
16
Re
Linezolid C N C C C C C C C C C I N C I N C C C N C C C C N C C C C Linezolid
Liposomal amphoB I N I I I I C C N C I C N C I N C C I N I I C I C I C I C Liposomal amphoB
M
pr
(AmBisome) (AmBisome)
cM
od
Lorazepam C C C C C N C C C C I I N C I N C C I C C N C C C C C C C Lorazepam
uc
ah in w
on
Mannitol C N C C C C C C C C C N C C I C C C N C C N C C I C C C C Mannitol
n
Meropenem C N N C I I N N C C N I N N N N N N N N I R C N N C C C C Meropenem
Pu
Methylprednisolone C N N C I N C C C C N I C C I N C N N I C C C C I I C I C Methylprednisolone
bl
Metoclopramide C N C C C C C C C C C N C C I C C C C I C C C C I C C C C Metoclopramide
is
ho
Metronidazole N C C C C C C C C C I N C I N C C C I C N C C C C C C C Metronidazole
hi
ng
le
Micafungin N I I I I C C C I I N N C I N N C C N N C C N N N C I N Micafungin
Midazolam C I C C C C C C C C I C C I C I C N N I C C C I C C C C Midazolam
or
Mycophenolate C I C C C C I C C C I N C I N I C I N I N C C I C C C C Mycophenolate
up
pa
Nicardipine C I C C C C C C C C I C C I N I C N N I C C C N C C C C Nicardipine
un ou
rt
Nitroglycerin C C C C C C C C C C N C C I C C C N C C G C C I C C C C Nitroglycerin
w
le
Nitroprussided C C C C I C C C C C N C C I C C C C C C C C C I C C C I Nitroprussided
ith
ss
Norepinephrine C C C C C C C C C C N C C I C C C N C I C C C I C C C C Norepinephrine
ot
Octreotide C I C C C C C C C C N N C I N C C C N C C C C C C C C C Octreotide
he
Ondansetron C I C C C C C C C C I C C I C C C C C I C C C I C C C C Ondansetron
tp
Pantoprazolee I N I N I I N N N N I N C I N N C I N N C N N N N C I I Pantoprazolee
rw
er
Penicillin G N N C C N C C C C N C N C I C N C N N N C C C I N C N N Penicillin G
is
m
Phenylephrine C C C C C C C C C C C C C I C C C N N C C C C I C C C C Phenylephrine
e
is
no
Phenytoin I I I I I I I I I I I I I I I I I N I I N I I I I I I I Phenytoin
si
on
Phytonadione N N C C N N C C C N C N C C I N C N N C C N C I C C N N Phytonadione
te
Piperacillin-tazobactam C N I C I I C C C C C N N C I N C C N C C C I C N C I C Piperacillin-tazobactam
d.
is
Propofol I N N N N N C C C N C N N N I N N C N C N N I N N N N N Propofol
ib
Tacrolimus C C C C C C C C C C C N C C I N C C C N C C C N C C C C Tacrolimus
Tobramycin C N C C C C C C C C C N C C I C I C N I C C C I C C C C Tobramycin
TMP-SMX C N I N I N I I I C I N I I I I C I N N I N N I I N C C TMP-SMX
Vancomycin C N C C C C C C C C C N N C I C N C N N N C C C I C C C Vancomycin
Vasopressin C C C C C C C C C C C C C C I C C C C N C N C C N C C C Vasopressin
Vecuronium C I C C C C C C C C C I N C I N I C C N C C C C C C C C Vecuronium
Voriconazole C N C C C C C I C C C I N C I N C C C N N C C C C C C C Voriconazole
a b c
Infisions exceeding 2 hours must be administered in glass or polyolefin containers. Unstable in solutions containing dextrose. Adsorbs to containers, tubing, and filters with which it comes into con-
tact. d Protect from light. e Testing was performed with ethylenediaminetetraacetic acid (EDTA)-free formulation.
P H A R M AC Y P R AC T I C E N E WS S P E C I A L E D I T I O N • 2 0 1 6
67
Text continued from page 61 help clinicians minimize their occurrence. Continuing
technique. Compatibility differences even have been research adding to the existing body of knowledge on
reported for different brands of the same drug. IV compatibilities is vital.
Three types of incompatibilities are commonly dis-
cussed: physical, chemical, and therapeutic. Physical Suggested Reading
incompatibilities are the most easily detected and are
Bertsche T, Mayer Y, Stahl R, et al. Prevention of intravenous drug
evidenced by visible changes, such as particulate for- incompatibilities in an intensive care unit. Am J Health Syst Pharm.
mation, haze, precipitation, color change, and gas evo- 2008;65(19):1834-1840.
lution. Chemical incompatibilities are those that result Cohen MR, Smetzer JL. ISMP medication error report analysis-drug
in decomposition of a drug. Loss of potency of greater stability and compatibility; proper use of single-dose vials; what
than 10% over the defined testing period is considered drugs are present on nursing units? Arixtra—not a hemostat;
Pradaxa–Plavix mix-up. Hosp Pharm. 2012;47(8):578-582.
A
ities can be detected only with a suitable analytical DRUGDEX® System (internet database). Greenwood Village, CO:
rig
Co
py
combination results in undesirable antagonistic or syn- Kanji S, Lam J, Johanson C, et al. Systematic review of physical and
s
rig ed.
ergistic pharmacologic activity, are beyond the scope of chemical compatibility of commonly used medications adminis-
re
2010;38(9):1890-1898.
The purpose of this chart is to provide data in an
rv
the type of incompatibility or compatibility is not spec- Am J Health Syst Pharm. 2010;67(2):108-112.
cM
od
ah in w
Chemother. 2013;68(5):1179-1182.
on
of compatibility. All conditions that may affect com- fosamil for injection with selected drugs during simulated Y-site
bl
patibility cannot be included in such a format, and it administration. Am J Health Syst Pharm. 2011;68(22):2163-2169.
is
McEvoy GK, ed. Handbook on Injectable Drugs. 18th ed. Bethesda, MD:
hi
arise, but it is hoped that the information provided may American Society of Health-System Pharmacists; 2015.
ng
le
or
G
ro
in
up
pa
un ou
rt
w
le
ith
ss
ot
he
tp
rw
er
is
m
e
is
no
si
on
te
d.
is
pr
oh
ib
ite
d.
68 P H A R M AC Y P R AC T I C E N E WS .CO M /S E 2 0 1 6